Phage Consultants returns to CPhI Worldwide
Press Release | Phage Consultants
OCTOBER 03, 2018
Phage Consultants made its CPhI debut in Frankfurt last autumn and found high interest in its a wide portfolio of specialist services, including deep expertise in keeping bacterial fermentations free from bacteriophage contamination that are highly relevant in biotech. The Gdansk-based laboratory is able to harness bacteriophage-based solutions for safeguarding sensitive biotech processes, biological reactions and bio fermentations.
Purification and Detection
The Phage Consultants stand will be at Booth 9J72 in Hall 9 at IFEMA Madrid as part of the Integrated Pharma Zone. Once again, Phage Consultants will be part of the Pomorskie Voivodeship (Pomeranian Province) presence, promoting the hi-tech companies clustered around Gdansk, which has become a center of excellence in the life sciences.
PC, led by CEO and co-founder Dr. Marcin Los, will be presenting an integrated portfolio of specialist services that both target bacteriophages and harness their power as powerful antibacterial and detection agents in their own right.
The stand will showcase Phage Production & Purification Services that can be used for development of phage-based drugs.
Bacteriophages as biosensors
“We are pleased to be returning to CPhI Worldwide, which we have found to be an excellent platform for meeting current customers and advertise our capabilities to future partners,” said Dr. Marcin Los.
For 2018, Phage Consultants will focus on its contamination control services and phage-based medicines development services, showing fermentation managers and other biotech professionals the necessity to keep their processes free of phages.
The team will also have details of advanced applications of phages in drug and medicine discovery that now include emerging techniques for using the viral characteristics of bacteriophages to eliminate bacteria, but also to recognize and bind specific bacterial receptors, enabling construction of stand-alone drugs, but also biosensors to recognize specific targets, formed by creating immobilized covalent bonds.
These open up promising research avenues for solving the problem of detecting many pathogenic and food borne bacteria, such as typhus or E. coli, in low concentrations that can defeat standard detection methods.
About Phage Consultants
Phage Consultants is a contract research and manufacturing organization that specializes in bacteriophage detection and characterization and production.
Bacteriophages (phages) are viruses that infect bacteria. First discovered around 1915, phages play an important role in viral biology, used to elucidate DNA viral reproduction through lytic and lysogenic cycles. They have been used for almost a century as alternatives to antibiotics and can have therapeutic effect against multi-drug-resistant strains of many bacteria.
Founded in Gdansk, Poland, in 2007, PC have become world leaders in using the power of bacteriophage technology in bioprocess infection and contamination control and assisting companies whose production is based on microbial activities in preventing bacteriophage contamination, along with bacterial, fungal and viral contaminations.
Phage Consultants are also specialists in the field of bacteriophage biology with specific expertise on phage activity in bioprocessing. Its team provides unique assistance to pharmaceutical and biotech companies, offering a range of services from personal training to consulting and process optimization in phage growth limitation. The company also advises and assists clients in the development of new production facilities.
About CPhI Worldwide 2018
CPhI Worldwide is the flagship annual trade show for pharma ingredients and partner sourcing providing delegates and exhibitors opportunities to arrange face-to-face meetings with potential international pharmaceutical partners and collaborators and gain insights on latest industry trends.
Now in its 29th year, the 2018 event is a three-day event opening October 9 at IFEMA, Feria de Madrid, Spain, which last hosted the event in 2015. CPhI Worldwide 2018. CPhI Worldwide includes the co-located zoned exhibitions; ICSE Outsourcing solutions, P-MEC Machinery and Equipment and InnoPack pharmaceutical packaging events. Together, they are expected to attract a record 45,000 delegates along with 2,500 exhibiting companies from 153 countries.
New for 2018, the Expo will feature bioLIVE, a new specialized exhibition focusing on the biopharmaceutical industry.
The CPhI series is staged by leading Global B2B Events Organizer and Publisher UBM Live More information at: https://www.cphi.com/europe/.
Dr. Marcin Los, CEO, Phage Consultants
Tel: +48 503 636 224